Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]
Latest News A New Clinical Practice Guideline for management of osteoporosis and fracture prevention in Canada October 10, 2023 On October 10, 2023, a new guideline on managing osteoporosis to […]